BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 38414015)

  • 1. Metabolic heterogeneity in clear cell renal cell carcinoma revealed by single-cell RNA sequencing and spatial transcriptomics.
    Yang G; Cheng J; Xu J; Shen C; Lu X; He C; Huang J; He M; Cheng J; Wang H
    J Transl Med; 2024 Feb; 22(1):210. PubMed ID: 38414015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting order amidst chaos of programmed cell deaths: construction of a diagnostic model for KIRC using transcriptomic information in blood-derived exosomes and single-cell multi-omics data in tumor microenvironment.
    Wang C; He Y; Zheng J; Wang X; Chen S
    Front Immunol; 2023; 14():1130513. PubMed ID: 37153569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-cell landscape and spatial transcriptomic analysis reveals macrophage infiltration and glycolytic metabolism in kidney renal clear cell carcinoma.
    Wen CY; Hsiao JH; Tzeng YT; Chang R; Tsang YL; Kuo CH; Li CJ
    Aging (Albany NY); 2023 Oct; 15(20):11298-11312. PubMed ID: 37847178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of single-cell RNA-seq and bulk RNA-seq revealed the heterogeneity and convergence of the immune microenvironment in renal cell carcinoma.
    Lv S; Tao L; Liao H; Huang Z; Lu Y
    Funct Integr Genomics; 2023 Jun; 23(2):193. PubMed ID: 37264263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting nucleotide metabolic pathways in colorectal cancer by integrating scRNA-seq, spatial transcriptome, and bulk RNA-seq data.
    Zhao S; Zhang P; Niu S; Xie J; Liu Y; Liu Y; Zhao N; Cheng C; Lu P
    Funct Integr Genomics; 2024 Apr; 24(2):72. PubMed ID: 38594466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cell transcriptomics reveals a low CD8
    Peng YL; Xiong LB; Zhou ZH; Ning K; Li Z; Wu ZS; Deng MH; Wei WS; Wang N; Zou XP; He ZS; Huang JW; Luo JH; Liu JY; Jia N; Cao Y; Han H; Guo SJ; Dong P; Yu CP; Zhou FJ; Zhang ZL
    J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35121646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of a Seven-Gene Signature Associated with CD8
    Chen Y; Zhou X; Xie Y; Wu J; Li T; Yu T; Pang Y; Du W
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancer.
    Li R; Ferdinand JR; Loudon KW; Bowyer GS; Laidlaw S; Muyas F; Mamanova L; Neves JB; Bolt L; Fasouli ES; Lawson ARJ; Young MD; Hooks Y; Oliver TRW; Butler TM; Armitage JN; Aho T; Riddick ACP; Gnanapragasam V; Welsh SJ; Meyer KB; Warren AY; Tran MGB; Stewart GD; Cortés-Ciriano I; Behjati S; Clatworthy MR; Campbell PJ; Teichmann SA; Mitchell TJ
    Cancer Cell; 2022 Dec; 40(12):1583-1599.e10. PubMed ID: 36423636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal-like Tumor Cells and Myofibroblastic Cancer-Associated Fibroblasts Are Associated with Progression and Immunotherapy Response of Clear Cell Renal Cell Carcinoma.
    Davidson G; Helleux A; Vano YA; Lindner V; Fattori A; Cerciat M; Elaidi RT; Verkarre V; Sun CM; Chevreau C; Bennamoun M; Lang H; Tricard T; Fridman WH; Sautes-Fridman C; Su X; Plassard D; Keime C; Thibault-Carpentier C; Barthelemy P; Oudard SM; Davidson I; Malouf GG
    Cancer Res; 2023 Sep; 83(17):2952-2969. PubMed ID: 37335139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Validation of UPF1 as a Novel Prognostic Biomarker in Renal Clear Cell Carcinoma.
    Wu C; Li H; Chang W; Zhong L; Zhang L; Wen Z; Mai S
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421841
    [No Abstract]   [Full Text] [Related]  

  • 11. Cellular senescence and metabolic reprogramming model based on bulk/single-cell RNA sequencing reveals PTGER4 as a therapeutic target for ccRCC.
    Zhou L; Zeng Y; Liu Y; Du K; Luo Y; Dai Y; Pan W; Zhang L; Zhang L; Tian F; Gu C
    BMC Cancer; 2024 Apr; 24(1):451. PubMed ID: 38605343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a polyamine gene expression score for predicting prognosis and treatment response in clear cell renal cell carcinoma.
    Chen M; Nie Z; Huang D; Gao Y; Cao H; Zheng L; Zhang S
    Front Immunol; 2022; 13():1048204. PubMed ID: 36505496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional enrichment analysis of LYSET and identification of related hub gene signatures as novel biomarkers to predict prognosis and immune infiltration status of clear cell renal cell carcinoma.
    Chen Y; He J; Jin T; Zhang Y; Ou Y
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16905-16929. PubMed ID: 37740762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating single-cell RNA-seq and spatial transcriptomics reveals MDK-NCL dependent immunosuppressive environment in endometrial carcinoma.
    Yu X; Xie L; Ge J; Li H; Zhong S; Liu X
    Front Immunol; 2023; 14():1145300. PubMed ID: 37081869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FCER1G positively relates to macrophage infiltration in clear cell renal cell carcinoma and contributes to unfavorable prognosis by regulating tumor immunity.
    Dong K; Chen W; Pan X; Wang H; Sun Y; Qian C; Chen W; Wang C; Yang F; Cui X
    BMC Cancer; 2022 Feb; 22(1):140. PubMed ID: 35120484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering the immune modulation through deep transcriptomic profiling and therapeutic implications of DNA damage repair pattern in hepatocellular carcinoma.
    Hong W; Zhang Y; Wang S; Zheng D; Hsu S; Zhou J; Fan J; Zeng Z; Wang N; Ding Z; Yu M; Gao Q; Du S
    Cancer Lett; 2024 Feb; 582():216594. PubMed ID: 38135208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidimensional Analyses of Tumor Immune Microenvironment Reveal the Possible Rationality of Immunotherapy and Identify High Immunotherapy Response Subtypes for Renal Papillary Cell Carcinoma.
    Wei B; Yu M; Yao J; Jiang M; An J; Yang J; Lin J; Zhao Y; Zhu Y
    Front Immunol; 2021; 12():657951. PubMed ID: 34531849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Niche-Specific Gene Signatures between Malignant Tumor Microenvironments by Integrating Single Cell and Spatial Transcriptomics Data.
    Saqib J; Park B; Jin Y; Seo J; Mo J; Kim J
    Genes (Basel); 2023 Oct; 14(11):. PubMed ID: 38002976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating scRNA and bulk-RNA sequencing develops a cell senescence signature for analyzing tumor heterogeneity in clear cell renal cell carcinoma.
    Gong Q; Jiang Y; Xiong J; Liu F; Guan J
    Front Immunol; 2023; 14():1199002. PubMed ID: 37503331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-Cell Transcriptome Analysis Reveals Intratumoral Heterogeneity in ccRCC, which Results in Different Clinical Outcomes.
    Hu J; Chen Z; Bao L; Zhou L; Hou Y; Liu L; Xiong M; Zhang Y; Wang B; Tao Z; Chen K
    Mol Ther; 2020 Jul; 28(7):1658-1672. PubMed ID: 32396851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.